Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Methods of treating inflammatory and autoimmune diseases with natalizumab

No-Receipt date 2019-03466 - 12/09/2019
No-Filing date 20190402794 - 12/09/2019
No-Granting date 3101312 - 29/10/2019
No-EPO application date 13175987.0 - 28/02/2007
No-EPO granting date 2676967 - 14/08/2019
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2019 - 28/11/2019
Expiration date 01/03/2027
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US776931 P28/02/2006/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 38/03
A61K 38/21
A61K 39/00
A61K 39/395
A61K 45/06
A61K 49/00
C07K 16/28
G01N 33/53
G01N 33/68

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1081793 BIOGEN MA INC. 225 BINNEY STREETCAMBRIDGE, MA 02142 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
2730393 LIEBERBURG, IVAN

Representatives
CodeFirstnameSurnameAddressTownZip
3178STEFANOS ALEXIOSTSIMIKALIS "TSIMIKALIS KALONAROU DIKIGORIKI ETAIREIA"NEOFYTOU VAMVA 1ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
8126STEFANOS ALEXIOSTSIMIKALISNEOFYTOU VAMVA 1ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 17 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015